Cargando…
941. Incarcerated patients living with HIV: Atherosclerotic cardiovascular disease risk and management
BACKGROUND: The 2018 American Heart Association and American College of Cardiology (AHA/ACC) 2018 Guideline on the Management of Blood Cholesterol included human immunodeficiency virus (HIV) as an atherosclerotic cardiovascular disease (ASCVD) risk enhancer for the first time. Our study investigates...
Autores principales: | Michienzi, Sarah M, Chiampas, Thomas D, Valkovec, Amy, Arzuaga, Siria, Patel, Mahesh C, Borgetti, Scott, Badowski, Melissa E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776467/ http://dx.doi.org/10.1093/ofid/ofaa439.1127 |
Ejemplares similares
-
Weight Gain in Incarcerated Individuals Living With HIV After
Switching to Integrase Strand Inhibitor-Based Therapy
por: Goldberg, Rachel N., et al.
Publicado: (2021) -
939. Immunity to Hepatitis A and/or Hepatitis B Viruses Among Inmates Living with HIV
por: Poondi, Nivedha, et al.
Publicado: (2020) -
1313. Complementary Effects of Medical Follow-up and Virologic Suppression for Reincarcerated Inmates Living with HIV
por: Badowski, Melissa E, et al.
Publicado: (2019) -
Immunologic and Virologic Outcomes of Obese and Nonobese Incarcerated Adults on Antiretroviral Therapy for HIV Infection
por: Bunnell, Kristen L., et al.
Publicado: (2018) -
1309. Effects of a Pharmacist-Driven Antiretroviral Stewardship and Transitions of Care Service in Persons Living with HIV/AIDS
por: Brizzi, Marisa B, et al.
Publicado: (2019)